Lynn Stockwell, CEO and Exe. Chair of Board: Drugs Made In America Acquisition DMAA Buy · Filed 25/02/18

Trade details

Type: Insider buy
Shares · price: 30,000 sh · price in footnote
Held after: 4,188,780 sh
Stock: Drugs Made In America Acquisition DMAA
Person: Lynn StockwellCEO and Exe. Chair of Board
Trade date: 25/02/18
Filed: 25/02/18
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +0.7%

Drugs Made In America Acquisition trades, last 26 weeks

What else happened in Drugs Made In America Acquisition around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Lynn Stockwell's recent trades

Lynn StockwellCEO and Exe. Chair of Board
BuyDrugs Made In America Acquisition II
Buy
Drugs Made In America Acquisition II
DMII
700,000 sh
price in footnote
700,000 sh
Filed 25/10/01
Traded 25/09/26
Lynn StockwellCEO and Exe. Chair of Board
SellDrugs Made In America Acquisition II
Sell
Drugs Made In America Acquisition II
DMII
7,966,667 sh
price in footnote
7,966,667 sh
Filed 25/10/01
Traded 25/09/26
Lynn StockwellCEO and Executive COB
BuyDrugs Made In America Acquisition
Buy
Drugs Made In America Acquisition
DMAA
400,000 sh
price in footnote
400,000 sh
Filed 25/02/04
Traded 25/01/29
Lynn StockwellCEO and Executive COB
SellDrugs Made In America Acquisition
Sell
Drugs Made In America Acquisition
DMAA
5,698,363 sh
price in footnote
5,698,363 sh
Filed 25/02/04
Traded 25/01/29
Lynn StockwellDirector
SellBright Green
Sell
Bright Green
BGXX
$360K
1,000,000 sh
$360K
Filed 24/06/10
Traded 24/06/05